Acute liver injury induced by red yeast rice supplement
- PMID: 30910808
- PMCID: PMC6510127
- DOI: 10.1136/bcr-2018-227961
Acute liver injury induced by red yeast rice supplement
Abstract
A 64-year-old woman previously taking no medications presented with acute hepatitis 6 weeks after starting a red yeast rice supplement to decrease her cholesterol. Red yeast rice is commonly used for hyperlipidaemia as an alternative to statins as it contains monacolin K, the same active chemical in lovastatin. Infectious, toxic and autoimmune causes for injury were ruled out, and liver biopsy was consistent with drug induced liver injury. Red yeast rice appeared to be the cause of her hepatotoxicity. After stopping the supplement and initiating treatment with intravenous methylprednisolone, liver enzymes decreased towards baseline.
Keywords: hepatitis other; unwanted effects/adverse reactions; vitamins and supplements.
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- Basseri B, Basseri R, McClune A. Drug-induced liver injury and drug eruption associated with initiation of red yeast rice. Am J Gastroenterol 2012;107:S433.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical